Concepedia

Anders Eneroth

AE

Statistics

Publications

11

Citations

353

H-Index

10

Active since

1991

Affiliations

Medivir (Sweden)(Current)

Uppsala University

Karolinska Institutet

AstraZeneca (Sweden)

Integrated Cardio Metabolic Centre

Anders Eneroth is an author at Medivir (Sweden) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1991–2021

11

Publications

11

Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction

Anders Eneroth, Eva Åström, Janet Hoogstraate et al. · European Journal of Pharmaceutical Sciences · 2001 · 111 citations

, , +7

Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors

Jürgen Brem, Tharindi Panduwawala, Jon Hansen et al. · Nature Chemistry · 2021 · 83 citations · Full text

, , +13

Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: Exploration of P2 quinazoline substituents

Magnus Nilsson, Anna Karin Belfrage, Stefan B. Lindström et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 24 citations

, , +15

Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors

Sandrine Vendeville, Magnus Nilsson, Herman de Kock et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 22 citations

, , +14

Interferon-?-like immunoreactivity in developing rat spinal ganglia neuronsin vivo andin vitro

Anders Eneroth, Krister Kristensson, �. Ljungdahl et al. · Journal of Neurocytology · 1991 · 21 citations

, , +11

1–5 of 11